Global Vasuclar Stents Market (Coronary Stents, Neurovascular Stents & Peripheral Vascular Stents) Market Outlook 2024

August 2018 | 72 pages | ID: G8BE6270EE7EN
Rockville Research

Abstracts

Advent of bioresorbable stents has brought about paradigm shift in interventional cardiology due to its promising safety and efficacy outcomes. The report “Global Vascular Stents Market (Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents)-Market Outlook 2024” provides information on the current scenario, market outlook of the global vascular stents market with detailed analysis of market segments such as Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global vascular stents market. The report has been segmented as following:-

Market Segments

• Coronary Artery Stents
• Neurovascular Stents
• Peripheral Vascular Stents

Geographical Coverage

• North America - The US
• Europe
• Asia Pacific

Companies Coverage

• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Microport Scientific Corporation

Contents

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. VASCULAR STENTS

3.1 Background
3.2 Overview
3.3 Classification

4. MARKET ANALYSIS

4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
  4.2.1 Market Share by Products
  4.2.2 Market share by Type
  4.2.3 Market Share by Region

5. MARKET SEGMENTATION

5.1 Coronary Stents
  5.1.1 Overview
  5.1.2 Market Sizing (Actual & Forecasted)
  5.1.3 Market Share by Products
    5.1.3.1 Bare Metal Stent
    5.1.3.2 Bioresorbable Stent
    5.1.3.3 Drug Eluting Stent
  5.1.4 Market Share by Region
5.2 Neurovascular Stents
  5.2.1 Overview
  5.2.2 Market Sizing (Actual & Forecasted)
5.3 Peripheral Vascular Stents
  5.3.1 Overview
  5.3.2 Market Sizing (Actual & Forecasted)
  5.3.3 Market Share by Products
    5.3.3.1 Femoral Artery Stent
    5.3.3.2 Infrapop Artery Stent
    5.3.3.3 Iliac Artery Stent
  5.3.5 Market Share by Region

6. REGIONAL ANALYSIS

6.1 North America
  6.1.1 Vascular Stent Market Sizing (Actual & Forecasted)
  6.1.2 Market Share by Stent Type
  6.1.3 The US
    6.1.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2 Europe
  6.2.1 Vascular Stent Market Sizing (Actual & Forecasted)
  6.2.2 Market Share by Stent Type
6.3 Asia Pacific
  6.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
  6.3.2 Market Share by Products

7. MARKET DYNAMICS

7.1 Industry Trend & Development
  7.1.1 Advent of Bioresorbable Vascular Stents
  7.1.2 Technological Advancement
7.2 Growth Drivers
  7.2.1 Increasing Geriatric Population
  7.2.2 Prevalence of Vascular Diseases
  7.2.3 Preference for Minimally Invasive Procedures
  7.2.4 Favorable Reimbursement Policies
7.3 Challenges
  7.3.1 Stringent Regulations
  7.3.2 Post-Operative Complications
  7.3.3 Slow Adoption Rate
  7.3.4 High Cost of Devices

8. COMPETITIVE LANDSCAPE

8.1 Market Share Analysis

9. COMPANY PROFILES

9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 Microport Scientific Corporation